IMAGE

Figure 3

ID
ZDB-IMAGE-230407-31
Source
Figures for Yang et al., 2023
Image
Figure Caption

Figure 3

Development of cerebral cavernous malformations in the Stk24/25idECKO mice.

(A) Schematic of 4-hydroxytamoxifen (HT) injection and sample collection. Pups were intragastrically injected with 4-HT at P2, and the brain tissues were harvested at specific time points (P7, P8, and P9). Stereomicroscopic images and μCT images of CCM lesions in control and the Stk24/25idECKO mice at P7, P8, and P9. Scale bars: 2 mm. Quantitative analysis of lesion volume in the cerebrum (n = 4) and cerebellum (n = 5) in the Stk24/25idECKO mice is shown on the right. Data in the quantitative plots are presented as mean ± SD. (B) H&E staining of brain sections in Stk24fl/flStk25fl/fl mice (n = 3) at P8 and Stk24/25idECKO mice (n = 3) at P7, P8, and P9. CCM lesions are shown as red masses. Scale bars: 100 μm. (C) Immunostainings of Pecam show cavernomas and reduced vascular number in Stk24/25idECKO mice (n = 4) compared with Stk24fl/fl;Stk25fl/fl mice (n = 4). The white arrowheads indicate malformed vessels. Scale bars: 50 μm. (D) The survival curve of Stk24/25idECKO (n = 20) and Stk24fl/fl;Stk25fl/fl (n = 21) mice after 4-HT induction at P2. Statistical analysis was performed using the Mantel-Cox test. ****P < 0.0001. Representative images from at least 3 or more independent experiments are shown.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ JCI Insight